Last reviewed · How we verify
Dyspepsia Prevention
Approved treatments
- Pepcid · Generic (originally Yamanouchi/Merck)
Competitively blocks histamine H2 receptors on gastric parietal cells, reducing basal and stimulated acid secretion.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Dyspepsia Prevention patent landscape — cliff calendar, originator estates, attackable patents
- Dyspepsia Prevention treatment landscape brief
- Dyspepsia Prevention treatment updates RSS
Frequently asked questions about Dyspepsia Prevention
What drugs treat Dyspepsia Prevention?
Tracked treatments include Pepcid.
What is the treatment for Dyspepsia Prevention?
Standard treatment for Dyspepsia Prevention includes Pepcid. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Dyspepsia Prevention patent cliff · Dyspepsia Prevention CI report
- Treatment: Pepcid · Generic (originally Yamanouchi/Merck)
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing